These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12122741)

  • 21. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease.
    Rasmussen HH; Fallingborg JF; Mortensen PB; Vyberg M; Tage-Jensen U; Rasmussen SN
    Scand J Gastroenterol; 1997 Jun; 32(6):604-10. PubMed ID: 9200295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
    Bonato G; Cristoferi L; Strazzabosco M; Fabris L
    Dig Dis; 2015; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary sclerosing cholangitis: diagnostic and therapeutic problems.
    Gotthardt D; Chahoud F; Sauer P
    Dig Dis; 2011; 29 Suppl 1():41-5. PubMed ID: 22104752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatobiliary complications of inflammatory bowel disease: overview of the issues.
    Balistreri WF
    Inflamm Bowel Dis; 1998 Aug; 4(3):220-4. PubMed ID: 9741026
    [No Abstract]   [Full Text] [Related]  

  • 26. [Primary sclerosing cholangitis].
    Boonstra K; Ponsioen CI; Rauws EA; Beuers U
    Ned Tijdschr Geneeskd; 2010; 154():A1476. PubMed ID: 20619015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U; Bergquist A
    Semin Liver Dis; 2006 Feb; 26(1):31-41. PubMed ID: 16496231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary sclerosing cholangitis.
    Rodriguez HJ; Bass NM
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent insights in primary sclerosing cholangitis.
    Ponsioen CY
    J Dig Dis; 2012 Jul; 13(7):337-41. PubMed ID: 22713082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
    Tischendorf JJ; Meier PN; Strassburg CP; Klempnauer J; Hecker H; Manns MP; Krüger M
    Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
    Fausa O; Schrumpf E; Elgjo K
    Semin Liver Dis; 1991 Feb; 11(1):31-9. PubMed ID: 2047887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary sclerosing cholangitis in children versus adults: lessons for the clinic.
    Adike A; Carey EJ; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1025-1032. PubMed ID: 30199272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatobiliary manifestations of inflammatory bowel disease.
    Yarur AJ; Czul F; Levy C
    Inflamm Bowel Dis; 2014 Sep; 20(9):1655-67. PubMed ID: 24874461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dilation of Strictures in Patients with Inflammatory Bowel Disease: Who, When and How.
    Coelho-Prabhu N; Martin JA
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):739-59. PubMed ID: 27633600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and therapeutic problems of primary sclerosing cholangitis.
    Colle I; Van Vlierberghe H
    Acta Gastroenterol Belg; 2003; 66(2):155-9. PubMed ID: 12891925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.
    Shiau H; Ihekweazu FD; Amin M; Fofanova T; Miloh T; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):404-409. PubMed ID: 28141677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatobiliary complications of inflammatory bowel disease.
    Bhutani MS; Rostami G; Gopalswamy N
    Am Fam Physician; 1995 Oct; 52(5):1440-4. PubMed ID: 7572566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.